| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CHX | Common Stock | Sale | -$664K | -18.8K | -5.29% | $35.39 | 336K | Aug 1, 2023 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. The shares were sold in multiple trades at prices ranging from $35.15 to $35.56, inclusive. The Reporting Person undertakes to provide, upon request, to the Securities and Exchange Commission staff, the Issuer or a security holder, full information regarding the number of shares and prices at which the transactions were effected. |
Chief Operating Officer and President, Chemical Technologies